MedTrace Logo

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

NCT01518049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-10-14

No results posted yet for this study

Summary

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Conditions

  • Affective Disorders, Psychotic

Sponsors & Collaborators

  • Søren Dinesen Østergaard

    lead OTHER

Principal Investigators

  • Søren D Østergaard, MD · Aahus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-09-30
Completion
2014-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01518049 on ClinicalTrials.gov